Literature DB >> 8370068

Identification of an S100 target protein: glycogen phosphorylase.

D B Zimmer1, J G Dubuisson.   

Abstract

An S100 binding protein from skeletal muscle, R95 000, has been purified, identified as glycogen phosphorylase, and shown to be regulated in vitro by the S100 alpha isoform. When a soluble skeletal muscle fraction was subjected to a standard purification procedure for glycogen phosphorylase, R95 000 copurified with the 95 000 molecular weight glycogen phosphorylase protein standard on SDS-polyacrylamide gels, as well as having glycogen phosphorylase activity. In addition, purified glycogen phosphorylase a and b interacted with both S100 isoforms, S100 alpha and S100 beta, by gel overlay and affinity chromatography. While S100 beta had no effect on the enzymatic activity of glycogen phosphorylase a, S100 alpha inhibited the enzymatic activity of glycogen phosphorylase a in a calcium-independent manner. Altogether, these data suggest that glycogen phosphorylase may be an intracellular S100 alpha target in skeletal muscle fibers. Furthermore, these results suggest that the inhibition of glycogen phosphorylase a activity may be responsible for the lack of fatigability of slow-twitch fibers, which express S100 alpha, when compared to fast-twitch fibers, which do not express S100 proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370068     DOI: 10.1016/0143-4160(93)90053-9

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  6 in total

1.  Identification of the binding site on S100B protein for the actin capping protein CapZ.

Authors:  P M Kilby; L J Van Eldik; G C Roberts
Journal:  Protein Sci       Date:  1997-12       Impact factor: 6.725

Review 2.  Calcium-dependent and -independent interactions of the S100 protein family.

Authors:  Liliana Santamaria-Kisiel; Anne C Rintala-Dempsey; Gary S Shaw
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

3.  The Calcium-Dependent Interaction of S100B with Its Protein Targets.

Authors:  Danna B Zimmer; David J Weber
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-17

4.  Intracellular and Extracellular Effects of S100B in the Cardiovascular Response to Disease.

Authors:  James N Tsoporis; Forough Mohammadzadeh; Thomas G Parker
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-07-07

5.  S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.

Authors:  Melissa S DeRycke; John D Andersen; Katherine M Harrington; Stefan E Pambuccian; Steve E Kalloger; Kristin L M Boylan; Peter A Argenta; Amy P N Skubitz
Journal:  Am J Clin Pathol       Date:  2009-12       Impact factor: 2.493

6.  Ca2+ -dependent interaction of S100A1 with F1-ATPase leads to an increased ATP content in cardiomyocytes.

Authors:  Melanie Boerries; Patrick Most; Jonathan R Gledhill; John E Walker; Hugo A Katus; Walter J Koch; Ueli Aebi; Cora-Ann Schoenenberger
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.